Table 3

Comparison 1: diet and physical activity versus usual care (main outcomes)

OutcomesAnticipated absolute effects* (95% CI)Relative effect
(95% CI)
Participants, n
(studies)
Certainty of the evidence
(GRADE)
Risk with usual careRisk with diet+physical
SBP (mm Hg)The mean SBP was 130.63 mm Hg.MD 2.72 mm Hg lower
(from 4.11 lower to 1.33 lower)
14 589
(12 RCTs)
⊕⊕⊕◯
Moderate†
SBP (mm Hg), no medicationsThe mean SBP, no medications, was 127.4 mm Hg.MD 1.72 mm Hg lower
(from 3.71 lower to 0.27 higher)
11 715
(5 RCTs)
⊕⊕⊕⊕High
SBP (mm Hg), medicationsThe mean SBP, medications, was 133.86 mm Hg.MD 3.61 mm Hg lower
(from 5.63 lower to 1.59 lower)
2874
(7 RCTs)
⊕⊕⊕ ◯
Moderate‡
DBP (mm Hg)The mean DBP was 85.39 mm Hg.MD 1.53 mm Hg lower
(from 2.57 lower to 0.48 lower)
14 527
(11 RCTs)
⊕⊕ ◯◯
Low§¶
DBP (mm Hg), no medicationsThe mean DBP, no medications, was 84.93 mm Hg.MD 0.67 mm Hg lower
(from 2.36 lower to 1.01 higher)
11 653
(4 RCTs)
⊕⊕⊕ ◯
Moderate**
DBP (mm Hg), medicationsThe mean DBP, medications, was 85.85 mm Hg.MD 2.05 mm Hg lower
(from 3.35 lower to 0.75 lower)
2874
(7 RCTs)
⊕⊕⊕ ◯
Moderate¶
Hypertension (yes/no)34 per 100016 per 1000
(6–46)
RR 0.47
(0.17–1.35)
635
(2 RCTs)
⊕⊕⊕ ◯
Moderate‡‡
Incidence of diabetes (yes/no)15 per 100018 per 1000
(6–60)
RR 1.25
(0.39–4.06)
661
(2 RCTs)
⊕⊕⊕ ◯
Moderate‡‡
  • *The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

  • *I2 statistic=54%, p=0.01, implying significant heterogeneity between studies without a lot of overlap in CIs.

  • †I2 statistic=58%, p=0.03, implying significant heterogeneity between studies without a lot of overlap in CIs.

  • ‡I2 statistic=67%, p=0.0008, implying significant heterogeneity between studies without a lot of overlap in CIs.

  • §Egger’s test: p=0.013.

  • ¶I2 statistic=61%, p=0.02, implying significant heterogeneity between studies without a lot of overlap in CIs.

  • **I2 statistic=69%, p=0.02, implying significant heterogeneity between studies without a lot of overlap in CIs.

  • ††Optimal Information Size (OIS) not met.

  • CI, confidence interval; DBP, diastolic blood pressure; MD, mean difference; RCT, randomised controlled trial; RR, relative risk; SBP, systolic blood pressure.